Interventional Cardiology Devices Market- Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2018-2028, Segmented By, Product Type (Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Others), By End User (Hospitals & Clinics, Ambulatory Surgery Centers, Others), By Region, and Competition

  • Industry : Healthcare
  • Pages : NA
  • Published Date : NA
Customization Enquiry

Buy Now

Summary

Report Description

Global Interventional Cardiology Devices Market is anticipated to observe an impressive growth during the forecast period, 2024-2028. The market owes its growth to the factors like increasing number of heart related diseases that are life threatening as well as the technological advancements in the medical devices that are introduced in this field.

The interventional cardiology devices are the tools that are used to perform surgical and diagnostic procedures that are required for the cardiovascular diseases specifically. Additionally, these procedures ensure recovery that is quick and efficient thereby supporting the market growth in the upcoming future. The availability of the various product that are specific to the various procedures for the diagnostics and the surgical procedures is driving the growth of the global interventional cardiovascular devices market in the forecast period.

Increasing Prevalence of Non-Communicable Diseases

 According to the WHO statistics, around 41 million people are killed each year suffering from Non-Communicable Diseases (NCD), out of which 17 million people die from NCD at the age below 70 years. The major factors contributing to the increasing risk of NCD are prevailing physical inactivity, excessive tobacco, and alcohol consumption Furthermore, non-communicable diseases have increased at an alarming rate due to poor choices on lifestyle. Population that are too accustomed with these lifestyle habits would drive the market growth of the global interventional cardiovascular devices market since the demand of the medical devices would increase. Health conditions such as strokes are nowadays causing a higher risk of death among the population. According to a WHO report, annually 15 million people worldwide are suffering stroke, out of which 5 million people are left disabled permanently. Stroke is less common among people under 40 years, and among those 65 years old suffering stroke, two-fifth of the stroke deaths were due to smoking. The rising cases of strokes is increasing with the growing ageing population across the world.  With the increasing cases of strokes worldwide there is a huge growing demand for interventional cardiovascular devices for undergoing different kind of cardiovascular surgery. Additionally, the growing prevalence of NCDs majorly cardiovascular diseases, with the increased awareness among the population is significantly creating a huge demand to monitor and treat patients and are thus simultaneously driving the global interventional cardiology devices market growth and is thereby anticipated to boost the market growth in the forecast period.

Growing Demand for Minimally Invasive Surgeries

Minimally invasive surgeries are surgeries performed with minimal invasion and are associated with reduced pain, lesser complications, and quicker recovery. Minimally invasive surgeries are best undergone various changes in techniques beneficial to the patient requiring a surgery. Minimally invasive surgeries are surgeries which can be done to treat several heart conditions, by offering minimal incision performed to reach the heart for initiating treatment and is highly recommended as it causes comparably less pain and quick recoveries than the other cardiac surgeries. These minimally invasive surgeries have huge advantage of lesser traumas in the patients going through these procedures. Several type of heart procedures are performed through minimally invasive surgeries such as Aortic valve replacement, Coronary artery bypass surgeries, Mitral valve repair or replacement, or atrioventricular septal defect surgery, etc. and therefore is aiding the patients with cardiovascular diseases. exposure to minimally invasive surgeries in both the diagnostic and treatment surgeries. The minimally invasive surgeries offer advantages over open heart surgeries such as less blood loss, reduced pain, smaller noticeable scars, lower infection risk, etc.

Minimally invasive surgeries demand smaller incisions than other traditional open-heart surgeries, which means that there is less scarring, reduced blood loss, and a quick recovery time. Patients also experience less pain and discomfort after the procedure, reducing the need for strong pain medications. Including minimally invasive surgeries, there is a reduced risk of infection because the incisions are minor, and there is a lesser exposure of the surgical site to external contaminants. Also, compared to the traditional open-heart surgeries, the minimally invasive surgeries have a shorter recovery time, allowing patients to return to their normal activities sooner. As a result, there has been an increased uptake of minimally invasive surgeries in cardiovascular procedures, leading to an overall increase in cardiovascular surgeries. Moreover, the increased adoption of minimally invasive coronary stents, high precision and cardiovascular devices are increasing the demand for the interventional cardiology devices market and thus are anticipated to support the market growth in future.

Growing Sedentary Lifestyle and Increasing Obesity Cases

Sedentary lifestyle and obesity are directly linked to cardiovascular devices. The rising consumption of processed food, sedentary lifestyle, and lack of physical activity have resulted in an increase in the incidence of obesity, diabetes, and hypertension. These risk factors increased the chances of developing heart disease, leading to a higher demand for interventional cardiology devices. Overweight and obesity increase the risk for many health issues, such as type 2 diabetes, high blood pressure, heart disease, stroke, and other conditions. Factors such as, processed food and drinks consumption, less exposure to physical activity, excessive time spent on sedentary behaviors, etc. lead to obesity and overweight condition thereby several creating health ailments. According to Centre for Disease Control and Prevention, in 2020, the US prevalence of obesity was 39.8% among adults aged 20 to 39 years, 44.3% among adults aged 40 to 59 years, and 41.5% among adults aged 60 and older. The increasing obesity cases leads to the increasing cases of cardiovascular diseases and other cardiac associated ailments among the population, thus creating a huge demand for cardiovascular treatments and surgical exposure. 

The leading cause of obesity that takes to cardiovascular disease is by causing disturbances s body’s metabolism and therefore leading to a condition such as stroke and other chronic inflammation. Excess body fat can increase the production of pro-inflammatory molecules, which can damage the lining of blood vessels and lead to the development of atherosclerosis. Obesity can also increase the risk of developing hypertension or high blood pressure, another significant risk factor for cardiovascular disease. When excess body fat is present, the body requires more blood to supply nutrients and oxygen to the tissue, which can cause an increase in blood pressure , which over time can damage blood vessels, increasing the risk of developing heart disease. Atherosclerosis is a condition in which the arteries become narrow and stiff, making it harder for blood to flow through them. This can lead to heart attacks, strokes, and other cardiovascular problems. Furthermore, obesity can also contribute to the development of type 2 diabetes, a condition that is associated with an increased risk of cardiovascular disease. In type 2 diabetes, the body becomes resistant to insulin, a hormone that regulates blood sugar levels and may lead to high blood sugar levels, which can further damage blood vessels and increase the risk of heart disease. Thus, flowing number of cases of obesity and sedentary lifestyle are expected to increase the demand for cardiovascular Devices, including interventional cardiology devices.

Recent Development

In 2022, the major technology, diagnostic and digital solutions innovator GE Healthcare collaborates with Boston Scientific- a major medical device manufacturer leader, to strengthen the potential of interventional cardiology and to offer advanced heart care in India. 


Download Free Sample Report

Market Segmentation

The global interventional cardiovascular devices market is segmented by product type, end user, regional distribution, and competitive landscape. Based on the product type, the market is segmented into, angioplasty balloons, angioplasty stents, structural heart devices, catheters, plaque modification devices, hemodynamic flow alteration devices, others. Depending on the end users, the market is grouped into hospitals & clinics, ambulatory surgery centers, and others.

Market Players

Medtronic Plc., Boston Scientific Corporation, Abbott Laboratories, Inc., Biotronik, Inc., Edward LifeSciences Corporation, Cardinal Health, Inc., iVascular - Dispositivos Cardiovasculares, B. Braun Melsungen AG, Terumo Corporation, Biosensors International Group Ltd. are some of the key players operating in the market.

Attribute

Details

Base Year

2022

Historical Years

2018 – 2021

Estimated Year

2023

Forecast Period

2024 – 2028

Quantitative Units

Revenue in USD Million and CAGR for 2018-2022 and 2023-2028

Report Coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered

       ·         Product Type

       ·         End User

Regional Scope

North America; Asia Pacific; Europe & CIS; South America; Middle East & Africa

Country Scope

United States; Canada; Mexico; China; India; Japan; South Korea; Australia; Germany; France; United Kingdom; Spain; Italy; Brazil; Argentina; Colombia; Saudi Arabia; UAE; South Africa; Kuwait

Key Companies Profiled

Medtronic Plc., Boston Scientific Corporation, Abbott Laboratories, Inc., Biotronik, Inc., Edward LifeSciences Corporation, Cardinal Health, Inc., iVascular - Dispositivos Cardiovasculares, B. Braun Melsungen AG, Terumo Corporation, Biosensors International Group Ltd, Cordis Corporation, Cook Medical Inc., C. R. Bard, Inc, MicroPort Scientific Corporation, Stentys SA

Customization Scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and Purchase Options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Report Scope:

In this report, global interventional cardiology devices market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Interventional Cardiology Devices Market, By Product Type:
    • Angioplasty Balloons
      • Old/Normal Balloons
      • Drug-eluting Balloons
      • Cutting and Scoring Balloons
    • Angioplasty Stents
      • Drug-eluting Stents
      • Bare-metal Stents
      • Bioabsorbable Stents
    • Structural Heart Devices
      • Aortic Valve Therapy Devices
      • Mitral Valve
      • Pulmonary Valve
      • Others
    • Catheters
      • Angiography Catheters
      • Guiding Catheters
      • IVUS/OCT Catheters
    • Plaque Modification Devices
      • Atherectomy Devices
      • Thrombectomy Devices
    • Hemodynamic Flow Alteration Devices
      • Embolic Protection Devices
      • Chronic Total Occlusion Devices
    • Others
  • Interventional Cardiology Devices Market, By End User:
    • Hospitals & Clinics
    • Ambulatory Surgery Centers
    • Others
  • Interventional Cardiology Devices Market, By Region:
    • North America
      • United States
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • United Kingdom
      • Italy
      • Spain
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE
      • Kuwait
    • South America
      • Brazil
      • Argentina
      • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global Interventional Cardiology Devices market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Global Interventional Cardiology Devices Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.    Markets Covered

1.2.2.    Years Considered for Study

1.2.3.    Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Sources

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, Trends

4.    Voice of Customer

5.    Clinical Trial Analysis

5.1.  Ongoing Clinical Trials

5.2.  Completed Clinical Trials

5.3.  Terminated Clinical Trials

5.4.  Breakdown of Pipeline, By Development Phase

5.5.  Breakdown of Pipeline, By Status

5.6.  Breakdown of Pipeline, By Study Application

5.7.  Breakdown of Pipeline, By Region

5.8.  Clinical Trials Heat Map

6.    Global Interventional Cardiology Devices Market Outlook

6.1.  Market Size & Forecast

6.1.1.    By Value

6.2.  Market Share & Forecast

6.2.1.    By Product Type (Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Others)

6.2.1.1.        By Angioplasty Balloons (Old/Normal Balloons, Drug-eluting Balloons, Cutting and Scoring Balloons)

6.2.1.2.        By Angioplasty Stents (Drug-eluting Stents, Bare-metal Stents, Bioabsorbable Stents)

6.2.1.3.        By Structural Heart Devices (Aortic Valve Therapy Devices, Mitral Valve, Pulmonary Valve, Others)

6.2.1.4.        By Catheters (Angiography Catheters, Guiding Catheters, IVUS/OCT Catheters)

6.2.1.5.        By Plaque Modification Devices (Atherectomy Devices v/s Thrombectomy Devices)

6.2.1.6.        By Hemodynamic Flow Alteration Devices (Embolic Protection Devices v/s Chronic Total Occlusion Devices)

6.2.2.    By End User (Hospitals & Clinics, Ambulatory Surgery Centers, Others)

6.2.3.    By Company (2022)

6.2.4.    By Region

6.3.  Product Market Map

7.    Asia-Pacific Interventional Cardiology Devices Market Outlook

7.1.  Market Size & Forecast        

7.1.1.    By Value

7.2.  Market Share & Forecast

7.2.1.    By Product Type

7.2.2.    By End User

7.2.3.    By Country

7.3.  Asia-Pacific: Country Analysis

7.3.1.    China Interventional Cardiology Devices Market Outlook

7.3.1.1.        Market Size & Forecast

7.3.1.1.1.            By Value

7.3.1.2.        Market Share & Forecast

7.3.1.2.1.            By Product Type

7.3.1.2.2.            By End User

7.3.2.    India Interventional Cardiology Devices Market Outlook

7.3.2.1.        Market Size & Forecast

7.3.2.1.1.            By Value

7.3.2.2.        Market Share & Forecast

7.3.2.2.1.            By Product Type

7.3.2.2.2.            By End User

7.3.3.    South Korea Interventional Cardiology Devices Market Outlook

7.3.3.1.        Market Size & Forecast

7.3.3.1.1.            By Value

7.3.3.2.        Market Share & Forecast

7.3.3.2.1.            By Product Type

7.3.3.2.2.            By End User

7.3.4.    Japan Interventional Cardiology Devices Market Outlook

7.3.4.1.        Market Size & Forecast

7.3.4.1.1.            By Value

7.3.4.2.        Market Share & Forecast

7.3.4.2.1.            By Product Type

7.3.4.2.2.            By End User

7.3.5.    Australia Interventional Cardiology Devices Market Outlook

7.3.5.1.        Market Size & Forecast

7.3.5.1.1.            By Value

7.3.5.2.        Market Share & Forecast

7.3.5.2.1.            By Product Type

7.3.5.2.2.            By End User

8.    Europe Interventional Cardiology Devices Market Outlook

8.1.  Market Size & Forecast        

8.1.1.    By Value

8.2.  Market Share & Forecast

8.2.1.    By Product Type

8.2.2.    By End User

8.2.3.    By Country

8.3.  Europe: Country Analysis

8.3.1.    France Interventional Cardiology Devices Market Outlook

8.3.1.1.        Market Size & Forecast

8.3.1.1.1.            By Value

8.3.1.2.        Market Share & Forecast

8.3.1.2.1.            By Product Type

8.3.1.2.2.            By End User

8.3.2.    Germany Interventional Cardiology Devices Market Outlook

8.3.2.1.        Market Size & Forecast

8.3.2.1.1.            By Value

8.3.2.2.        Market Share & Forecast

8.3.2.2.1.            By Product Type

8.3.2.2.2.            By End User

8.3.3.    United Kingdom Interventional Cardiology Devices Market Outlook

8.3.3.1.        Market Size & Forecast

8.3.3.1.1.            By Value

8.3.3.2.        Market Share & Forecast

8.3.3.2.1.            By Product Type

8.3.3.2.2.            By End User

8.3.4.    Italy Interventional Cardiology Devices Market Outlook

8.3.4.1.        Market Size & Forecast

8.3.4.1.1.            By Value

8.3.4.2.        Market Share & Forecast

8.3.4.2.1.            By Product Type

8.3.4.2.2.            By End User

8.3.5.    Spain Interventional Cardiology Devices Market Outlook

8.3.5.1.        Market Size & Forecast

8.3.5.1.1.            By Value

8.3.5.2.        Market Share & Forecast

8.3.5.2.1.            By Product Type

8.3.5.2.2.            By End User

9.    North America Interventional Cardiology Devices Market Outlook

9.1.  Market Size & Forecast        

9.1.1.    By Value

9.2.  Market Share & Forecast

9.2.1.    By Product Type

9.2.2.    By End User

9.2.3.    By Country

9.3.  North America: Country Analysis

9.3.1.    United States Interventional Cardiology Devices Market Outlook

9.3.1.1.        Market Size & Forecast

9.3.1.1.1.            By Value

9.3.1.2.        Market Share & Forecast

9.3.1.2.1.            By Product Type

9.3.1.2.2.            By End User

9.3.2.    Mexico Interventional Cardiology Devices Market Outlook

9.3.2.1.        Market Size & Forecast

9.3.2.1.1.            By Value

9.3.2.2.        Market Share & Forecast

9.3.2.2.1.            By Product Type

9.3.2.2.2.            By End User

9.3.3.    Canada Interventional Cardiology Devices Market Outlook

9.3.3.1.        Market Size & Forecast

9.3.3.1.1.            By Value

9.3.3.2.        Market Share & Forecast

9.3.3.2.1.            By Product Type

9.3.3.2.2.            By End User

10.  South America Interventional Cardiology Devices Market Outlook

10.1.             Market Size & Forecast         

10.1.1. By Value

10.2.             Market Share & Forecast

10.2.1. By Product Type

10.2.2. By End User

10.2.3. By Country

10.3.             South America: Country Analysis

10.3.1. Brazil Interventional Cardiology Devices Market Outlook

10.3.1.1.     Market Size & Forecast

10.3.1.1.1.         By Value

10.3.1.2.     Market Share & Forecast

10.3.1.2.1.         By Product Type

10.3.1.2.2.         By End User

10.3.2. Argentina Interventional Cardiology Devices Market Outlook

10.3.2.1.     Market Size & Forecast

10.3.2.1.1.         By Value

10.3.2.2.     Market Share & Forecast

10.3.2.2.1.         By Product Type

10.3.2.2.2.         By End User

10.3.3. Colombia Interventional Cardiology Devices Market Outlook

10.3.3.1.     Market Size & Forecast

10.3.3.1.1.         By Value

10.3.3.2.     Market Share & Forecast

10.3.3.2.1.         By Product Type

10.3.3.2.2.         By End User

11.  Middle East and Africa Interventional Cardiology Devices Market Outlook

11.1.             Market Size & Forecast         

11.1.1. By Value

11.2.             Market Share & Forecast

11.2.1. By Product Type

11.2.2. By End User

11.2.3. By Country

11.3.             MEA: Country Analysis

11.3.1. South Africa Interventional Cardiology Devices Market Outlook

11.3.1.1.     Market Size & Forecast

11.3.1.1.1.         By Value

11.3.1.2.     Market Share & Forecast

11.3.1.2.1.         By Product Type

11.3.1.2.2.         By End User

11.3.2. Saudi Arabia Interventional Cardiology Devices Market Outlook

11.3.2.1.     Market Size & Forecast

11.3.2.1.1.         By Value

11.3.2.2.     Market Share & Forecast

11.3.2.2.1.         By Product Type

11.3.2.2.2.         By End User

11.3.3. UAE Interventional Cardiology Devices Market Outlook

11.3.3.1.     Market Size & Forecast

11.3.3.1.1.         By Value

11.3.3.2.     Market Share & Forecast

11.3.3.2.1.         By Product Type

11.3.3.2.2.         By End User

11.3.4. Kuwait Interventional Cardiology Devices Market Outlook

11.3.4.1.     Market Size & Forecast

11.3.4.1.1.         By Value

11.3.4.2.     Market Share & Forecast

11.3.4.2.1.         By Product Type

11.3.4.2.2.         By End User

12.  Market Dynamics

12.1.             Drivers

12.2.             Challenges

13.  Market Trends & Developments

13.1.             Recent Developments

13.2.             Mergers & Acquisitions

13.3.             Product Developments

14.  Competitive Landscape

14.1.             Business Overview

14.2.             Company Snapshot

14.3.             Products & Services

14.4.             Financials (In case of listed companies)

14.5.             Recent Developments

14.6.             SWOT Analysis

14.6.1. Medtronic Plc.

14.6.2. Boston Scientific Corporation

14.6.3. Abbott Laboratories, Inc.

14.6.4. Biotronik, Inc.

14.6.5. Edward LifeSciences Corporation

14.6.6. Cardinal Health, Inc.

14.6.7. iVascular - Dispositivos Cardiovasculares

14.6.8. B. Braun Melsungen AG

14.6.9. Terumo Corporation

14.6.10.               Biosensors International Group Ltd.

15.  Strategic Recommendations

Figures and Tables

Frequently asked questions

down-arrow

Rising prevalence of cardiovascular diseases along with the growing technological advancements in the medical devices are driving the growth of the global interventional cardiology devices market in the forecast years, 2024-2028.

down-arrow

Medtronic Plc., Boston Scientific Corporation, Abbott Laboratories, Inc., Biotronik, Inc., Edward LifeSciences Corporation, Cardinal Health, Inc., among others are leading the global interventional cardiology devices market in the forecast period, 2024-2028.

down-arrow

North America is expected to dominate the global interventional cardiology devices market analysis in the forecast period, on account of growing prevalence of cardiovascular diseases and increased healthcare expenditure and high disposable income.

down-arrow

New market players may invest actively in research and innovative product development. Also, advancing their existent technology according to evolving consumer preferences along with merger and acquisitions with the global giants can be viable strategic recommendations for the future brand establishments.

Related Reports

profile

Sakshi Bajaal

Business Consultant
Press Release

Interventional Cardiology Devices Market to grow at an Impressive CAGR During the Forecast Period

Apr, 2021

Rising prevalence of cardiovascular diseases is driving the growth in Global Interventional Cardiology Devices Market in the forecast period, 2022-2026.

Why Choose Us